title: Desmopressin (Octostim®) before a native kidney biopsy can reduce the risk for biopsy complications in patients with impaired renal function: A pilot study.
abstract: OBJECTIVE
  To evaluate whether the administration of desmopressin alters the risk for renal biopsy complications.
  
  
  METHODS
  A multicenter registry containing 576 native kidney biopsies (NKb) with a serum creatinine above 150 μmol/L in 527 patients (372 men and 155 women, median age 61 years) was used. Most of the data were prospective. At one of the hospitals all biopsies with creatinine above 150 μmol/L received desmopressin before biopsies (NKb 204). These were compared to outcome of biopsy complications against other centres where desmopressin was not given (NKb 372). Fisher's exact test, χ2analyses, univariate and multiple binary logistic regression were used. Data were given as odds ratio (OR) and confidence interval (CI). A two sided P-value of <0.05 was considered significant.
  
  
  RESULTS
  In NKb with creatinine >150 μmol/L, those with desmopressin had less overall (3.4% vs 8.4%, OR 0.39, CI 0.17-0.90) whereas major or minor complications were not different. While desmopressin did not exhibit difference in complications in men, women received less major (0% vs 8.6%, P = 0.03) and overall complications (0% vs 12.1%, P = 0.006). A multiple logistic regression revealed that, after adjusting for BMI, age and sex, prophylaxis with desmopressin showed less major (OR 0.38, CI 0.15-0.96) and overall complications (OR 0.36, CI 0.15-0.85).
  
  
  CONCLUSIONS
  Desmopressin given before a native kidney biopsy in patients with impaired renal function can reduce the risk for complications.
authors.affiliation: Department of Nephrology, Skaraborg Hospital, Skövde, Sweden.|Department of Public Health and Clinical Medicine, Umeå University, Gothenburg, Sweden.
authors.forename: Björn
authors.initials: B
authors.lastname: Peters
authors.affiliation: Department of Nephrology, Skaraborg Hospital, Skövde, Sweden.
authors.forename: Henrik
authors.initials: H
authors.lastname: Hadimeri
authors.affiliation: Department of Pathology, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
authors.forename: Johan
authors.initials: J
authors.lastname: Mölne
authors.affiliation: Department of Research Center (FoU), Skaraborg Hospital, Skövde, Sweden.
authors.forename: Salmir
authors.initials: S
authors.lastname: Nasic
authors.affiliation: Department of Nephrology, Sahlgrenska University Hospital, Gothenburg, Sweden.
authors.forename: Gert
authors.initials: G
authors.lastname: Jensen
authors.affiliation: Department of Public Health and Clinical Medicine, Umeå University, Gothenburg, Sweden.
authors.forename: Bernd
authors.initials: B
authors.lastname: Stegmayr
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy / Q000009:adverse effects*; D016009:Chi-Square Distribution; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage*; D005260:Female; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006490:Hemostatics / Q000008:administration & dosage*; D006801:Humans; D007668:Kidney / Q000473:pathology* / Q000503:physiopathology; D007674:Kidney Diseases / Q000473:pathology* / Q000503:physiopathology; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D016017:Odds Ratio; D010865:Pilot Projects; D011237:Predictive Value of Tests; D011446:Prospective Studies; D065840:Protective Factors; D012042:Registries; D012189:Retrospective Studies; D012307:Risk Factors; D013548:Sweden; D055815:Young Adult
chemical_list: D006490:Hemostatics; D003894:Deamino Arginine Vasopressin
keywords: Desmopressin; biopsy complications; kidney biopsy; renal biopsy